258 related articles for article (PubMed ID: 26032022)
1. Hepatokines: unlocking the multi-organ network in metabolic diseases.
Iroz A; Couty JP; Postic C
Diabetologia; 2015 Aug; 58(8):1699-703. PubMed ID: 26032022
[TBL] [Abstract][Full Text] [Related]
2. Role of exercise-induced hepatokines in metabolic disorders.
Ennequin G; Sirvent P; Whitham M
Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E11-E24. PubMed ID: 30964704
[TBL] [Abstract][Full Text] [Related]
3. Interaction between hepatokines and metabolic diseases.
Liang JQ; Liu C; Zhang WX; Chen SY
Yi Chuan; 2022 Oct; 44(10):853-866. PubMed ID: 36384723
[TBL] [Abstract][Full Text] [Related]
4. Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men.
Willis SA; Sargeant JA; Yates T; Takamura T; Takayama H; Gupta V; Brittain E; Crawford J; Parry SA; Thackray AE; Varela-Mato V; Stensel DJ; Woods RM; Hulston CJ; Aithal GP; King JA
J Nutr; 2020 May; 150(5):1076-1085. PubMed ID: 31919514
[TBL] [Abstract][Full Text] [Related]
5. Hepatokines and metabolism: Deciphering communication from the liver.
Jensen-Cody SO; Potthoff MJ
Mol Metab; 2021 Feb; 44():101138. PubMed ID: 33285302
[TBL] [Abstract][Full Text] [Related]
6. Future of muscle research in diabetes: a look into the crystal ball.
Roden M
Diabetologia; 2015 Aug; 58(8):1693-8. PubMed ID: 26003326
[TBL] [Abstract][Full Text] [Related]
7. The future of brown adipose tissues in the treatment of type 2 diabetes.
Schrauwen P; van Marken Lichtenbelt WD; Spiegelman BM
Diabetologia; 2015 Aug; 58(8):1704-7. PubMed ID: 25957230
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines.
Oh KJ; Lee DS; Kim WK; Han BS; Lee SC; Bae KH
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025491
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Liver Fat to Weight Loss-Induced Changes in Serum Hepatokines: A Randomized Controlled Trial.
Telgenkamp I; Kusters YHAM; Schalkwijk CG; Houben AJHM; Kooi ME; Lindeboom L; Bons JAP; Schaper NC; Joris PJ; Plat J; Mensink RP; Stehouwer CDA; Brouwers MCGJ
J Clin Endocrinol Metab; 2019 Jul; 104(7):2719-2727. PubMed ID: 30753672
[TBL] [Abstract][Full Text] [Related]
10. Implication of hepatokines in metabolic disorders and cardiovascular diseases.
Jung TW; Yoo HJ; Choi KM
BBA Clin; 2016 Jun; 5():108-13. PubMed ID: 27051596
[TBL] [Abstract][Full Text] [Related]
11. Hepatokines-a novel group of exercise factors.
Weigert C; Hoene M; Plomgaard P
Pflugers Arch; 2019 Mar; 471(3):383-396. PubMed ID: 30338347
[TBL] [Abstract][Full Text] [Related]
12. The erosion of physical activity in Western societies: an economic death march.
Booth FW; Hawley JA
Diabetologia; 2015 Aug; 58(8):1730-4. PubMed ID: 25952481
[TBL] [Abstract][Full Text] [Related]
13. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases.
Abu-Farha M; Abubaker J; Tuomilehto J
Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28722798
[TBL] [Abstract][Full Text] [Related]
14. Ectopic lipid storage and insulin resistance: a harmful relationship.
Borén J; Taskinen MR; Olofsson SO; Levin M
J Intern Med; 2013 Jul; 274(1):25-40. PubMed ID: 23551521
[TBL] [Abstract][Full Text] [Related]
15. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
Meex RCR; Watt MJ
Nat Rev Endocrinol; 2017 Sep; 13(9):509-520. PubMed ID: 28621339
[TBL] [Abstract][Full Text] [Related]
16. FGF21-based pharmacotherapy--potential utility for metabolic disorders.
Gimeno RE; Moller DE
Trends Endocrinol Metab; 2014 Jun; 25(6):303-11. PubMed ID: 24709036
[TBL] [Abstract][Full Text] [Related]
17. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
Kim TH; Hong DG; Yang YM
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944728
[TBL] [Abstract][Full Text] [Related]
18. The implication of hepatokines in metabolic syndrome.
Esfahani M; Baranchi M; Goodarzi MT
Diabetes Metab Syndr; 2019; 13(4):2477-2480. PubMed ID: 31405664
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.
Owen BM; Mangelsdorf DJ; Kliewer SA
Trends Endocrinol Metab; 2015 Jan; 26(1):22-9. PubMed ID: 25476453
[TBL] [Abstract][Full Text] [Related]
20. Role of fetuin-A in atherosclerosis associated with diabetic patients.
Singh M; Sharma PK; Garg VK; Mondal SC; Singh AK; Kumar N
J Pharm Pharmacol; 2012 Dec; 64(12):1703-8. PubMed ID: 23146032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]